Clinical Trials Directory

Trials / Completed

CompletedNCT06153927

Diagnostic Performance of On-site Automatic Coronary Computed Tomography Angiography-derived Fractional Flow Reserve

Status
Completed
Phase
Study type
Observational
Enrollment
332 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The current study evaluated the diagnostic performance for myocardial ischemia of on-site automatic CCTA-derived FFR (CT-FFR) using a commercially available workstation as compared with invasive FFR as a reference. The diagnostic performance of CT-FFR was compared to that of CCTA diameter stenosis.

Detailed description

This is a retrospective, multicenter, comparative, investigator-initiated study to evaluate the diagnostic performance of CT-FFR from routinely acquired CCTA data using the software HeartMedi+ 1.0 (AI Medic, Korea) to detect hemodynamically significant CAD. Patients who underwent CCTA within 90 days before invasive coronary angiography and FFR measurement will be screened in each participating center. After that, invasive coronary angiography, FFR data, and CCTA data will be anonymized and transferred to the independent core laboratories and analyzed in a blind fashion. The presence of ischemia was defined as FFR ≤0.80. Anatomical obstructive stenosis was defined as diameter stenosis on CCTA ≥50%, and the diagnostic performance of CT-FFR and CCTA stenosis for ischemia was compared.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT-FFRCT-FFR was calculated using HeartMedi+ 1.0 according to the manufacturer's instructions

Timeline

Start date
2022-05-26
Primary completion
2023-07-30
Completion
2023-10-31
First posted
2023-12-01
Last updated
2023-12-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06153927. Inclusion in this directory is not an endorsement.